基于工程化Td PIE技术在益生菌大肠杆菌中构建的哑铃型siRNA生产可扩展平台
A Scalable Platform for Dumbbell siRNA Production Using Engineered Td PIE in Probiotic E. coli
Zhibo Huang, Shaojiao Wang, Jinhao Liu, Yude Lin, Zhiwei Xiao, Tienan Chen, Bo Shi, Sijie Gu, Rujiang Zhou, Zhengju Yao, Xizhi Guo
Journal:Molecular Therapy-Nucleic Acids
IF:6.5
DOI:10.1016/j.omtn.2026.103030
PMID:
Published:2026-07-22
research field:基因治疗生物材料生物医学工程纤维化研究伤口愈合
Abstract
Despite the clinical success of siRNA therapeutics, limitations including rapid degradation, off-target effects, and high manufacturing costs hinder broader application. Circular siRNAs, particularly dumbbell-shaped variants (db-siRNAs), offer enhanced stability and prolonged activity but lack scalable production methods. Here, we developed a streamlined platform for db-siRNA biosynthesis using a minimized T4 phage thymidylate synthase ( Td ) group I intron permuted intron-exon (PIE) system. By embedding essential splicing motifs into one terminal loop, we achieved ∼85% cyclization efficiency both in vitro and in vivo . Using engineered Escherichia coli Nissle 1917 (EcN), we established a low-immunogenicity production system, which could yield functional db-siRNAs at 60 mg/L in a fed-batch fermentation with a 3 L bioreactor. Db-siRNAs with 23-bp stems demonstrated optimal gene silencing for over 10 days in vitro and effectively reduced target expression in vivo when formulated with lipid nanoparticles. Our platform enables rapid, cost-effective production of stable, potent db-siRNAs for preclinical development, addressing key manufacturing challenges in RNAi therapeutics.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


